Dr. Adam Striker speaks with Dr. Jason Chi, editor for Summaries of Emerging Evidence (SEE), about two topics featured in SEE Volume 42A: the relationship between sedation type and the rate of precancerous polyp detection in colonoscopies, and rates of respiratory and acute cardiovascular complications, as well as 30-day mortality in patients with chronic kidney disease who received neuromuscular blocking agents (NMBAs). Recorded January 2026.
<p></p>


<description>Dr. Adam Striker speaks with Dr. Jason Chi, editor for Summaries of Emerging Evidence (SEE), about two topics featured in SEE Volume 42A: the relationship between sedation type and the rate of precancerous polyp detection in colonoscopies, and rates of respiratory and acute cardiovascular complications, as well as 30-day mortality in patients with chronic kidney disease who received neuromuscular blocking agents (NMBAs). Recorded January 2026.
&lt;p&gt;&lt;/p&gt;
</description>

Dr. Adam Striker speaks with Dr. Jason Chi, editor for Summaries of Emerging Evidence (SEE), about two topics featured in SEE Volume 42A: the relationship between sedation type and the rate of precancerous polyp detection in colonoscopies, and rates of respiratory and acute cardiovascular complications, as well as 30-day mortality in patients with chronic kidney disease who received neuromuscular blocking agents (NMBAs).

Central Line by American Society of Anesthesiologists - a podcast series for the anesthesia community

Impact of Sedation Type on Polyp Detection and of NMBAs in Patients with Chronic Kidney Disease

Impact of Sedation Type on Polyp Detection and of NMBAs in Patients with Chronic Kidney Disease

Description